
Overview
Background
A/Prof Mark D. Chatfield is a highly experienced statistician and clinical trialist working at the UQ Clinical Trials Centre.
In collaboration with health and medical researchers, he has published >200 times in academic journals. He has been an investigator on 28 NHMRC/MRFF funded (>$56M) studies (mostly clinical trials). He has co-supervised 5 PhD students to completion, and is currently an advisor to 4 PhD students. He has over 20 years of experience as a biostatistician in Australia (Brisbane | Darwin | Sydney) and the UK (Cambridge, 2002-2009).
He plays an active role in the Australian Clinical Trials Alliance Statistics in Trials Interest Group.
Stata users around the world enjoy using his table1_mc command.
He is an Honorary Fellow (Associate Professor) with Menzies School of Health Research.
Availability
- Mr Mark Chatfield is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Arts, University of Oxford
- Masters (Coursework), University of Southampton
- Masters (Coursework), University of Oxford
Research interests
-
Randomised Controlled Trials (RCTs)
Mark has been involved with a plethora of trials of various designs in a broad range of fields. He makes considered, significant contributions to funding applications, trial design, analysis, presentation and interpretation. To date, he has published on 39 randomised trials (protocol and/or results paper). He is involved with methodological research into cluster randomised trials as well as sample size calculations and the anticipated width of 95% confidence intervals.
-
Ready interpretation of log-scale ouput
Ready interpretation of log-scale ouput such as SD(ln Y), Bias(ln estimator). Symmetric percentage differences such as 100(A – B)/0.5(A + B)% or 100(lnA – lnB)%, Bland-Altman plots, and the summarising, modelling and plotting of lognormal data.
-
Meta analysis
Mark has been involved with a variety of meta-analyses. He has found a novel way to interpret the heterogeneity parameter, tau, in random-effects meta-analysis of various ratios (e.g. odds ratio, ratio of means etc). He advocates for the reporting of tau (or exp(tau) for ratio measures) rather than tau^2 as it makes appreciating heterogeneity easier.
Works
Search Professor Mark Chatfield’s works on UQ eSpace
2012
Conference Publication
EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (RCC) (ANZUP trial 0901)
Davis, Ian D., Gebski, Val, Chatfield, Mark D., Grimison, Peter S., Kannourakis, George, Boland, Amy L., Thompson, Jennifer and Stockler, Martin R. (2012). EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (RCC) (ANZUP trial 0901). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.
2012
Journal Article
HDR brachytherapy combined with external beam radiation for localised prostate cancer: early experience from the Sydney Cancer Centre
Whalley, Deborah, Patanjali, Nitya, Jackson, Michael, Lovett, Aimee, Chatfield, Mark and Hruby, George (2012). HDR brachytherapy combined with external beam radiation for localised prostate cancer: early experience from the Sydney Cancer Centre. Journal of Medical Imaging and Radiation Oncology, 56 (2), 220-226. doi: 10.1111/j.1754-9485.2012.02358.x
2012
Conference Publication
Accelerated BEP for metastatic germ cell tumors: Combined analysis of Australian and UK phase I/II trials
Grimison, Peter S., Chatfield, Mark D., Mazhar, Danish, Toner, Guy C., Chester, John D., Stockler, Martin R., Stark, Daniel P., Thomson, Damien B., Shamash, Jonathan, Friedlander, Michael, White, Jeff, Gebski, Val, Wason, James, Boland, Amy L., Rimmer, Yvonne L., McDonald, Angus, Gurney, Howard, Rosenthal, Mark, Singhal, Nimit and Williams, Michael V. (2012). Accelerated BEP for metastatic germ cell tumors: Combined analysis of Australian and UK phase I/II trials. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il United States, 01-06 June 2012. Alexandria, VA United States: American Society of Clinical Oncology.
2011
Journal Article
Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy
Kao, Steven Chuan-Hao, Klebe, Sonja, Henderson, Douglas W., Reid, Glen, Chatfield, Mark, Armstrong, Nicola J., Yan, Tristan D., Vardy, Janette, Clarke, Stephen, van Zandwijk, Nico and McCaughan, Brian (2011). Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology, 6 (11), 1923-1929. doi: 10.1097/JTO.0b013e31822a3740
2011
Conference Publication
CALRETININ EXPRESSION IMPROVES THE PREDICTIVE ACCURACY IN SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) UNDERGOING EXTRAPLEURAL PNEUMONECTOMY (EPP)
Kao, Steven C., Klebe, Sonja, Henderson, Douglas W., Reid, Glen, Chatfield, Mark, Armstrong, Nicola, Yan, Tristan, Vardy, Janette, Clarke, Stephen, Van Zandwijk, Nico and Mccaughan, Brian (2011). CALRETININ EXPRESSION IMPROVES THE PREDICTIVE ACCURACY IN SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) UNDERGOING EXTRAPLEURAL PNEUMONECTOMY (EPP). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
2011
Conference Publication
MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC)
Yip, Po Yee, Cooper, Wendy, Mahar, Annabelle, Kench, James, Kohonen-Corish, Maija R. J., Chatfield, Mark, Boulghourjian, Alice, Kennedy, Catherine W., Mccaughan, Brian, Boyer, Michael and Horvath, Lisa (2011). MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
2011
Conference Publication
PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN A COHORT OF PATIENTS COMPENSATED BY THE DUST DISEASES BOARD
Kao, Steven C., Clarke, Stephen, Chatfield, Mark, Corte, Peter, Clarke, Christopher, Vardy, Janette and Van Zandwijk, Nico (2011). PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN A COHORT OF PATIENTS COMPENSATED BY THE DUST DISEASES BOARD. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
2011
Journal Article
Clinical validation study to measure the performance of the nerve root sedimentation sign for the diagnosis of lumbar spinal stenosis
Staub, Lukas P., Barz, Thomas, Melloh, Markus, Lord, Sarah J., Chatfield, Mark and Bossuyt, Patrick M. (2011). Clinical validation study to measure the performance of the nerve root sedimentation sign for the diagnosis of lumbar spinal stenosis. Contemporary Clinical Trials, 32 (3), 470-474. doi: 10.1016/j.cct.2011.01.015
2011
Journal Article
The reliability of assigning individuals to cognitive states using the Mini Mental-State Examination: a population-based prospective cohort study
Marioni, Riccardo E., Chatfield, Mark, Brayne, Carol, Matthews, Fiona E. and Medical Research Council Cognitive Function and Ageing Study Group (2011). The reliability of assigning individuals to cognitive states using the Mini Mental-State Examination: a population-based prospective cohort study. BMC Medical Research Methodology, 11 (1) 127, 127.1-127.6. doi: 10.1186/1471-2288-11-127
2010
Journal Article
Validity of a New Abdominal Bioelectrical Impedance Device to Measure Abdominal and Visceral Fat: Comparison With MRI
Browning, Lucy M., Mugridge, Owen, Chatfield, Mark D., Dixon, Adrian K., Aitken, Sri W., Joubert, Ilse, Prentice, Andrew M. and Jebb, Susan A. (2010). Validity of a New Abdominal Bioelectrical Impedance Device to Measure Abdominal and Visceral Fat: Comparison With MRI. Obesity, 18 (12), 2385-2391. doi: 10.1038/oby.2010.71
2010
Journal Article
Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial
Jebb, Susan A., Lovegrove, Julie A., Griffin, Bruce A., Frost, Gary S., Moore, Carmel S., Chatfield, Mark D., Bluck, Les J., Williams, Christine M. and Sanders, Thomas A. B. (2010). Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. American Journal of Clinical Nutrition, 92 (4), 748-758. doi: 10.3945/ajcn.2009.29096
2010
Journal Article
Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLEheart study, a randomised, controlled dietary intervention
Brownlee, Iain A., Moore, Carmel, Chatfield, Mark, Richardson, David P., Ashby, Peter, Kuznesof, Sharron A., Jebb, Susan A. and Seal, Chris J. (2010). Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLEheart study, a randomised, controlled dietary intervention. British Journal of Nutrition, 104 (1), 125-134. doi: 10.1017/S0007114510000644
2009
Journal Article
An algorithm to assess intestinal iron availability for use in dietary surveys
Rickard, Anna P., Chatfield, Mark D., Conway, Rana E., Stephen, Alison M. and Powell, Jonathan J. (2009). An algorithm to assess intestinal iron availability for use in dietary surveys. British Journal of Nutrition, 102 (11), 1678-1685. doi: 10.1017/S0007114509990894
2009
Journal Article
Lewy bodies and neuronal loss in subcortical areas and disability in non-demented older people: a population based neuropathological cohort study
Byford, M., Brayne, C., McKeith, I., Chatfield, M., Ince, P. G. and Matthews, F. E. (2009). Lewy bodies and neuronal loss in subcortical areas and disability in non-demented older people: a population based neuropathological cohort study. BMC Geriatrics, 9 (1) 22. doi: 10.1186/1471-2318-9-22
2009
Journal Article
Successful Manipulation of the Quality and Quantity of Fat and Carbohydrate Consumed by Free-Living Individuals Using a Food Exchange Model
Moore, Carmel, Gitau, Rachel, Goff, Louise, Lewis, Fiona J., Griffin, Margaret D., Chatfield, Mark D., Jebb, Susan A., Frost, Gary S., Sanders, Tom A. B., Griffin, Bruce A. and Lovegrove, Julie A. (2009). Successful Manipulation of the Quality and Quantity of Fat and Carbohydrate Consumed by Free-Living Individuals Using a Food Exchange Model. Journal of Nutrition, 139 (8), 1534-1540. doi: 10.3945/jn.108.103374
2009
Journal Article
Bone mass and geometry of the tibia and the radius of master sprinters, middle and long distance runners, race-walkers and sedentary control participants: A pQCT study
Wilks, D. C., Winwood, K., Gilliver, S. F., Kwiet, A., Chatfield, M., Michaelis, I., Sun, L. W., Ferretti, J. L., Sargeant, A. J., Felsenberg, D. and Rittweger, J. (2009). Bone mass and geometry of the tibia and the radius of master sprinters, middle and long distance runners, race-walkers and sedentary control participants: A pQCT study. Bone, 45 (1), 91-97. doi: 10.1016/j.bone.2009.03.660
2009
Journal Article
The Skillings-Mack test (Friedman test when there are missing data)
Chatfield, Mark and Mander, Adrian (2009). The Skillings-Mack test (Friedman test when there are missing data). Stata Journal, 9 (2), 299-305. doi: 10.1177/1536867X0900900208
2008
Journal Article
Community-level socio-economic status and cognitive and functional impairment in the older population
Basta, Nicole E., Matthews, Fiona E., Chatfield, Mark D. and Brayne, Carol (2008). Community-level socio-economic status and cognitive and functional impairment in the older population. European Journal of Public Health, 18 (1), 48-54. doi: 10.1093/eurpub/ckm076
2008
Conference Publication
Designing an algorithm to calculate intestinal iron availability
Rickard, Anna P., Chatfield, Mark D., Stephen, Alison M. and Powell, Jonathan J. (2008). Designing an algorithm to calculate intestinal iron availability. 10th International Symposium on Metal Ions in Biology and Medicine, Bastia France, May 19-22, 2008. MONTROUGE: JOHN LIBBEY EUROTEXT.
2007
Journal Article
Using the mini-mental state examination for tracking cognition in the older population based on longitudinal data
Chatfield, Mark, Matthews, Fiona E. and Brayne, Carol (2007). Using the mini-mental state examination for tracking cognition in the older population based on longitudinal data. Journal of the American Geriatrics Society, 55 (7), 1066-1071. doi: 10.1111/j.1532-5415.2007.01216.x
Funding
Current funding
Past funding
Supervision
Availability
- Mr Mark Chatfield is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Statistical advisor (but NOT primary supervisor)
I am available to be a statistical advisor, but am not available to be a primary supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Treatment Strategies for Extended-Spectrum Beta-Lactamase (ESBL) and AmpC-producing Enterobacterales
Associate Advisor
Other advisors: Dr Patrick Harris, Dr Brian Forde
-
Doctor Philosophy
Randomised controlled trial of ceftolozane-tazobactam vs meropenem for bloodstream infections
Associate Advisor
Other advisors: Dr Patrick Harris, Dr Brian Forde
-
Doctor Philosophy
Novel trial design in evaluation of antibiotics.
Associate Advisor
Other advisors: Dr Patrick Harris
-
Doctor Philosophy
Gram-negative bloodstream infections in Australian children
Associate Advisor
Other advisors: Dr Geoff Spurling, Professor Colleen Lau, Associate Professor Adam Irwin
-
Doctor Philosophy
Exploring the use of causal inference in infectious disease epidemiology
Associate Advisor
Other advisors: Professor Tracy Comans, Professor Lisa Hall
-
Doctor Philosophy
Exploring the use of causal inference in infectious disease epidemiology
Associate Advisor
Other advisors: Professor Tracy Comans, Professor Lisa Hall
-
Doctor Philosophy
Burkholderia pseudomallei: towards rapid diagnosis and management
Associate Advisor
Other advisors: Dr Patrick Harris
Completed supervision
-
2024
Doctor Philosophy
Burkholderia pseudomallei: towards rapid diagnosis and management
Associate Advisor
Other advisors: Dr Patrick Harris
-
Media
Enquiries
For media enquiries about Mr Mark Chatfield's areas of expertise, story ideas and help finding experts, contact our Media team: